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Even though colorectal cancer is less prevalent than various other oncological diseases of other organs, it still remains a very serious 
affliction. Complete resection of the tumor and its zone of lymphogenic metastasis is still the main method of treatment.
Common principles of surgical treatment of colon cancer are: radicalness, ablastics, asepticism and providing safe way for gastric 
contents to exit, preferably in a natural way. The success of surgical treatment largely depends on proper preparation of the colon.
In the last years, colorectal cancer with regional extension forms requiring surgical and complex treatment, became more and more 
widespread.
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Conference participants
clinical studies are the basis for promoting the modern methods 
of treatment, introduction of new 
medications for clinical usage, as well as 
the diagnostic and therapeutic procedures. 
Involvement in the clinical studies is 
primarily based on assuring the security 
of the patient and getting a complete 
course of treatment by the patient 
regardless of the group he/she is in.
In the last decades colorectal cancer 
took the leading position among other 
oncological diseases in Europe and USA, 
but the mortality rate has decreased to 
40% since the 90’s.
Epidemiologic investigations in most 
developed countries helped discover a 
close connection between the increasing 
morbidity rate of the colorectal cancer 
and three main factors:
• The increasing consumption of 
animal fats and proteins;
• The decreasing consumption of 
dietary fibres. Excessive refinement of 
carbohydrates leads to the reduction 
of the non-absorbable cellulose, which 
represents a kind of absorbents for 
exogenous and endogenous carcinogenic 
substances; it also leads to increase 
in time it takes for substances to pass 
through the intestines.
• The less dynamic style of living of 
modern individuals, which also leads to 
the decreased passage speed through the 
intestines.
Colorectal cancer is the third in 
frequency both in men (663,904 cases, 
representing 10.0% of all malignancies) 
and women (571,204 cases - 9.4% of all 
malignancies) in the whole world. New 
research on colorectal cancer (CRC) 
has been imposed by the continuous 
increase of the disease incidence both in 
developed countries, which have already 
registered high levels of prevalence, and 
in countries where CRC rates were not 
concerning before. Colorectal cancer 
(CRC) is nowadays one of the most 
frequent malignant tumours in the 
Western world, leading to local invasion 
or adhesion to surrounding organs in 5% 
to 20% of the patients. Such situation may 
demand different operative strategies and 
technical skills from the surgical team. In 
this context, a proper oncologic approach 
includes an en-bloc multivisceral 
resection of all organs and/or structures 
involved. Since the distinction 
between inflammatory or neoplastic 
adhesions can only be achieved through 
pathological assessment, separation 
of the affected organs is not advised 
to prevent dissemination of malignant 
cells and tumour perforation. Although 
locally advanced colorectal lesions were 
considered inoperable just a couple of 
decades ago, more extensive procedures 
are nowadays the only chance for a cure, 
besides the actions with potentially 
greater operative risk. Locally advanced 
primary and locally advanced recurrent 
cancer of the colon and the rectum are 
surgically challenging due to clinical 
presumption of tumour involvement 
in others stru  ctures and organs. The 
estimated need for extensive surgical 
resection, often with multiviscseral en-
bloc resection is crucial for preoperative 
surgical planning. As for the primary 
and the recurrent tumours, postoperative 
long-term survival is achievable, but 
only after complete R0-resection. 
The role of neoadjuvant and adjuvant 
therapy continues to be prevalent in 
this era of biological chemotherapies 
as a multimodal treatment providing an 
opportunity for the technical realization 
of resection and improving the long-
term survival. Definition of locally 
advanced disease is necessary in order to 
achieve practical and theoretical clarity 
regarding a relatively big percentage 
of patients with colorectal cancer who 
are to be treated by a surgeon. Some 
patients with cancer of the colon or 
rectum present a different shape and 
extent of locally advanced primary or 
recurrent tumour, but in the stage of non-
metastatic disease, which, despite the 
lack of generalization, might be resected. 
Unresectability criteria are variable and 
not clearly defined.
Purpose of the research: To 
improve results of complex treatment 
of colorectal cancer with local-regional 
extension through the study of clinical 
specificity of colorectal cancer with 
local-regional extension; to create 
new methods of surgical and complex 
treatment.
Materials and methods: The study 
group consisting of 86 patients.
The vast majority of patients with 
colorectal cancer with expansion to the 
adjacent organs were in the sixth decade 
of their life (34.9%), followed by patients 
in the fifth decade (29.1%). The patients 
were mainly female - 53.5%, compared 
to the male percentage of 46.5%.
Results and discussion: CC with 
tumour extension to adjacent organs and 
tissues most often (39.5%) occurred in 
the sigmoid intestine, followed by the 
ascending portion (20.9%), hepatic angle 
(16.3%), cecum (13.9%), descending 
colon (4.7%), transverse colon and 
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splenic angle (2.3%). Out of 86 patients, II 
(T3-4 NO MO) evolutionary stages of the 
disease were in 46.5% patients. It should 
be noted that in this group of patients in 33 
cases out of 40 (82.5%) the evolutionary 
stage of the disease was classified as 
T4tumour with invasion of the intestinal 
wall, including the serous layer, and in 
some cases intestinal mesentery. A group 
of patients with metastases in regional 
lymph nodes represents 53.5% cases. In 
most cases (51.2%) is extended as colon 
cancer tumour locations compared to 
the left colon (46.5% cases). Organs and 
tissues that were involved in the neoplastic 
process: retroperitoneal and pasranefral 
tissue (27.9%), small intestine (20.9%), 
abdominal wall (14%), mesocolon (14%). 
Uterine annexes, uterus (8.1%), urinary 
bladder (4.7%) were involved in the 
cases of sigmoid bowel cancer tumours. 
In 89.5% of cases after tumour excision, 
the restoration of intestine continuity 
did not require protective colostomy. 
9 (10.5%) patients wes used the reason 
for the association of intestinal occlusion 
was used colon resection with intestinal 
anastomosis with application of protective 
colostomy. 
ICC was performed over 50 (58.1%) 
patients. The most common ICC were in 
the small intestine and colon resections-
18 (20.9%) patients and abdominal wall 
resection-12 (13.9%) patients. In 13.9% 
of cases affected colon tumours invaded 
meso, 17.4% and 10.5% retroperitoneal 
tissue and paranefral tissue respectively. 
Operations performed under such 
conditions were considered as typical. 
Overall, ICC-removal of a segment 
of bowel with tumours was done to 
50 (58.1%) patients. In 36 (41.9%) patients 
with local colon cancer that spread to 
meso- and paranefral and retroperitoneal 
tissue typical operations were performed 
depending on tumour localization. 
The most common colon resections 
ICC were combined with resection 
of the small intestine in 20.9% cases. 
Pathomorphological study of pieces 
removed in surgery brought to a 
conclusion that tumour invasion of the 
neighbouring organs in 67.4% of cases 
and the tumour adjacent organ damage 
in 32.6% of cases proved to be of 
inflammatory origin.
Colorectal cancer is extremely 
susceptible for treatment in its early 
stages. That is why scientists are 
carrying out expositional work regarding 
periodical health examinations and are 
also developing different methods for 
early diagnosing of the disease.
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